An Open-Label, Single and Multiple Oral Dose Pharmacokinetic Study of Vigabatrin in Infants With Infantile Spasms.
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 12 Sep 2012
At a glance
- Drugs Vigabatrin (Primary)
- Indications Infantile spasms
- Focus Pharmacokinetics
- Sponsors Lundbeck Inc
- 12 Sep 2012 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov record.
- 08 May 2012 Planned initiation date changed from 1 Apr 2012 to 1 Jun 2012 as reported by ClinicalTrials.gov.
- 17 Feb 2012 Planned initiation date changed from 1 Jan 2012 to 1 Apr 2012 as reported by ClinicalTrials.gov.